Yatharth Hospital & Trauma Care Services Ltd

- The company currently has a strong cash position of around Rs. 300 crores and is sitting on zero debt as of the latest update. - For funding the upcoming CAPEX (around Rs. 1,400 - Rs. 1,500 crores over three years), the company plans to use a mix of internal accruals, existing cash reserves, and debt if needed. - There is no explicit mention of a new equity fundraising in the immediate future. - Management indicated the ability to fund expansions through internal accruals, cash on hand, and possibly debt, but no confirmed plans yet for new debt issuance. - The company remains open to exploring debt funding in the future if necessary, but currently is well-capitalized to fund growth internally.

- The company plans cumulative CAPEX of around Rs. 1,400 to Rs. 1,500 crores over the next three years covering both Brownfield and Greenfield expansions. - Brownfield expansions include around 450 beds at Greater Noida and Noida Extension Hospitals with CAPEX of Rs. 60-70 lakh per bed. - Greenfield projects target adding around 300 to 350 beds including land, with a CAPEX of approximately Rs. 300 crores. - Future expansions may add about 1,200 beds with CAPEX per bed around Rs. 1 crore. - The company is evaluating acquisitions including stressed assets and land parcels in NCR and other big cities for growth beyond the 3,000-bed target. - Existing cash position is around Rs. 300 crores, with zero debt and expected strong internal accruals to fund expansion. - Maintenance CAPEX is relatively low, estimated at Rs. 20-25 crores annually.

- The company expects a revenue growth of around 30% annually, consistent with past years. - Expansion plans include achieving a bed capacity of 3,000 beds by FY 2028, potentially sooner due to faster additions. - Beyond 3,000 beds, the company plans to continue scaling up with similar momentum focused within the North India market. - Existing hospitals are targeted to reach approximately 75% occupancy within a couple of years. - New hospitals (Delhi and Faridabad) are expected to ramp up occupancy to 30%-35% after the first year of operations. - ARPOB (Average Revenue Per Occupied Bed) is projected to grow around 8%-10% annually. - Growth in specialty services like oncology and transplants is anticipated, with an expected rise in specialty charges contributing to revenue. - International patient business is growing but will remain around 10% of revenue, positively impacting ARPOB without hurting margins.

- Revenue growth guidance remains around 30% annually, consistent with recent years. - EBITDA margin expected to stabilize around 24% for the full year, similar to Q4 FY '25 levels. - Net profit has grown 38% year-over-year and 9% quarter-over-quarter, indicating strong profitability momentum. - ARPOB (Average Revenue Per Occupied Bed) projected to grow 8-10% annually in FY '26 and FY '27. - Two new hospitals expected to ramp up occupancy to 30-35% after one year, positively impacting group occupancy and earnings. - Existing hospitals targeted to achieve group-level occupancy of about 75% within a couple of years, improving operational efficiency. - Strong net cash position (~Rs. 300 crores) with zero debt supports funding expansions without stressing profitability. - Internal accruals and cash reserves will primarily fund CAPEX, limiting dilution or increased interest burden. - Overall, growth in earnings and operating profits is expected to be robust, driven by expansion in higher-paying, larger cities and improved operational metrics.

The transcript from the earnings call does not explicitly mention the current or expected order book or pending orders for Yatharth Hospitals and Trauma Care Services Limited. Key points related to growth and expansion include: - The company is actively expanding bed capacity, targeting 3,000 beds by FY 2028, with potential to achieve this earlier. - Recent acquisitions include hospitals in New Delhi, Greater Faridabad, and Faridabad. - They are focusing on both Greenfield (new builds) and Brownfield (expansion of existing facilities) projects. - CAPEX guidance of Rs. 1,400-1,500 crores is planned to add approximately 1,200 beds. - Financing will come from cash reserves (around Rs. 300 crore), zero debt position, and internal accruals. - Expansion strategy focuses on larger cities and capital regions rather than Tier III cities. No direct details on order book or pending contract values were provided in the document.